Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr263 Inhibitors

Olr263 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Olr263 receptor, which belongs to the vast family of olfactory receptors. These receptors are typically G-protein-coupled receptors (GPCRs) located primarily in the olfactory epithelium, playing a crucial role in the detection of odorant molecules. The Olr263 receptor is part of a highly diverse and complex network that allows organisms to detect and differentiate a wide range of chemical stimuli in the environment. Inhibition of Olr263 activity can be accomplished through a variety of mechanisms, such as competitive binding at the receptor's active site, allosteric modulation, or interference with downstream signaling pathways associated with the receptor. The molecular structure of Olr263 inhibitors often reflects the need to fit precisely within the receptor's binding pocket, which can involve intricate interactions with specific amino acid residues that stabilize the receptor-ligand complex.

Research into Olr263 inhibitors involves the synthesis and characterization of compounds that can selectively interact with the Olr263 receptor. Structural biology techniques, such as X-ray crystallography or cryo-electron microscopy, are employed to determine the receptor's three-dimensional structure, providing valuable insights into potential binding sites and interaction motifs. This structural information guides the design of inhibitors, where medicinal chemistry approaches are used to optimize the binding affinity and specificity of these compounds. Additionally, computational modeling and molecular docking studies are frequently utilized to predict the binding modes and energetics of potential inhibitors. These approaches facilitate the identification of key structural features that contribute to the inhibition of Olr263, guiding the synthesis of more potent and selective compounds. The study of Olr263 inhibitors not only enhances the understanding of olfactory receptor function but also contributes to broader knowledge in the field of GPCR signaling and ligand-receptor interactions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that could interfere with the phosphorylation state of Olr263, potentially altering its activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that might influence signaling pathways related to the function of Olr263, thereby modulating its activity indirectly.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that could induce the accumulation of misfolded or damaged proteins, potentially affecting Olr263's turnover or function.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that inhibits calcineurin; could affect signaling pathways indirectly associated with Olr263.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK, which is part of the MAPK pathway, potentially affecting pathways that Olr263 is involved in.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, potentially affecting pathways that Olr263 might be involved in, hence modulating its activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor, potentially influencing signaling pathways related to Olr263's function.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that might affect the degradation pathway of Olr263, influencing its levels and activity.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$166.00
$306.00
$1675.00
18
(1)

A calmodulin antagonist, potentially affecting calcium signaling pathways related to Olr263.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, part of the MAPK pathway, which could indirectly affect Olr263's activity.